Agilon Health, Inc. $AGL Stock Holdings Lifted by Amundi

Key Points

• Amundi increased its stake in Agilon Health by 49.2%, acquiring an additional 489,414 shares, and now holds a total of 1,484,709 shares worth $5,939,000.
• Analysts have reduced their target prices for Agilon Health significantly, with Sanford C. Bernstein lowering it to $1.40, and Robert W. Baird dropping it to $1.00 while maintaining a "neutral" rating.
• Agilon Health's stock is currently trading at $1.13, down 2.2%, and analysts predict a negative earnings per share of -0.59 for the current fiscal year.

Amundi raised its stake in shares of Agilon Health, Inc. (NYSE:AGL - Free Report) by 49.2% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,484,709 shares of the company's stock after buying an additional 489,414 shares during the quarter. Amundi owned about 0.36% of Agilon Health worth $5,939,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Raymond James Financial Inc. acquired a new stake in shares of Agilon Health during the fourth quarter worth $33,000. Nisa Investment Advisors LLC raised its position in shares of Agilon Health by 244.9% in the 1st quarter. Nisa Investment Advisors LLC now owns 9,553 shares of the company's stock worth $41,000 after buying an additional 6,783 shares during the period. Gabelli Funds LLC purchased a new position in shares of Agilon Health in the 1st quarter worth $48,000. Ridgecrest Wealth Partners LLC purchased a new position in shares of Agilon Health in the 1st quarter worth $65,000. Finally, Pallas Capital Advisors LLC purchased a new position in Agilon Health in the first quarter valued at about $66,000.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on AGL. Jefferies Financial Group lowered their target price on Agilon Health from $2.40 to $1.10 and set a "hold" rating for the company in a research note on Friday, August 15th. Benchmark decreased their price target on Agilon Health from $4.00 to $1.50 and set a "buy" rating for the company in a research note on Wednesday, August 6th. Robert W. Baird decreased their price target on Agilon Health from $5.00 to $1.00 and set a "neutral" rating for the company in a research note on Thursday, August 14th. Evercore ISI decreased their target price on Agilon Health from $5.00 to $3.00 and set an "in-line" rating for the company in a research note on Wednesday, July 9th. Finally, Barclays decreased their target price on Agilon Health from $3.00 to $1.50 and set an "underweight" rating for the company in a research note on Wednesday, August 6th. Four research analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, Agilon Health currently has a consensus rating of "Hold" and a consensus price target of $3.07.

Agilon Health Stock Up 0.9%

Agilon Health stock traded up $0.01 during mid-day trading on Tuesday, hitting $1.12. 7,809,762 shares of the company's stock traded hands, compared to its average volume of 6,248,546. The firm has a 50 day moving average price of $1.50 and a 200 day moving average price of $2.72. The company has a market cap of $464.15 million, a PE ratio of -1.45 and a beta of 0.11. Agilon Health, Inc. has a one year low of $0.71 and a one year high of $6.08.

Agilon Health (NYSE:AGL - Get Free Report) last released its earnings results on Monday, August 4th. The company reported ($0.25) earnings per share for the quarter, missing analysts' consensus estimates of ($0.11) by ($0.14). Agilon Health had a negative return on equity of 66.76% and a negative net margin of 5.35%.The firm had revenue of $1.39 billion during the quarter, compared to analyst estimates of $1.47 billion. During the same quarter last year, the company earned ($0.07) earnings per share. The business's revenue for the quarter was down 5.9% on a year-over-year basis. On average, analysts expect that Agilon Health, Inc. will post -0.59 earnings per share for the current fiscal year.

Agilon Health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.